What are transparent blur spots after photocoagulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transparent Blur Spots After Photocoagulation

Transparent blur spots after photocoagulation are primarily scotomas (blind spots) that develop in approximately 60-70% of patients as a result of thermal damage to retinal tissue during laser treatment. 1 These spots represent areas where laser burns have created localized damage to retinal tissue, resulting in visual field defects that patients may perceive as transparent or blurry areas in their vision.

Characteristics and Pathophysiology

  • These transparent blur spots are a direct result of the intended therapeutic effect of photocoagulation, which creates thermal burns in the retina to achieve tissue coagulation 2
  • The appearance of these spots varies based on:
    • Laser parameters (duration, power, spot size)
    • Type of photocoagulation performed (focal, panretinal, or grid)
    • Underlying condition being treated 1
  • The blur spots develop because photocoagulation intentionally creates localized damage to treat conditions like diabetic retinopathy or retinal vein occlusions

Risk Factors for More Prominent Blur Spots

  • Higher laser power settings
  • Longer duration of laser application
  • More extensive treatment areas (such as panretinal photocoagulation)
  • Treatment performed in a single intensive session rather than multiple sessions 2
  • Treatment of areas closer to the macula 1

Clinical Significance

  • Most transparent blur spots are permanent but may become less noticeable over time as the patient adapts
  • The visual impact varies depending on:
    • Location of treatment (peripheral vs. central)
    • Density of laser spots applied
    • Individual patient factors 1
  • Despite these visual disturbances, the American Academy of Ophthalmology and American Diabetes Association note that the benefits of preventing severe vision loss generally outweigh the risks of these visual disturbances 1

Management Considerations

  • Patient education before photocoagulation is essential to set appropriate expectations
  • Newer laser delivery systems (such as multispot pattern lasers) have reduced but not eliminated these complications 2
  • Modified treatment parameters can help minimize discomfort and potentially reduce the severity of blur spots:
    • Shorter exposure times (0.02s vs. traditional 0.1s) with adjusted power settings can achieve similar therapeutic effects with less pain 3
    • Multiple treatment sessions with fewer spots per session may reduce the severity of visual disturbances

When to Seek Additional Care

Patients should be advised to report immediately if they experience:

  • Sudden decrease in vision
  • New or increased floaters
  • Eye pain or redness
  • Significant worsening of visual field defects 1

These symptoms could indicate complications beyond normal post-photocoagulation scotomas, such as:

  • Macular edema (reported incidence of 8% after panretinal photocoagulation)
  • Vitreous hemorrhage (1-5% incidence)
  • Choroidal effusions or exudative retinal detachments 1, 2

Regular follow-up examinations are recommended after photocoagulation, including visual acuity testing, undilated slit-lamp biomicroscopy, pupillary assessment, IOP measurement, and stereoscopic examination of the posterior pole 1.

References

Guideline

Complications of Photocoagulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Panretinal Photocoagulation: A Review of Complications.

Seminars in ophthalmology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.